- Home
- THCH vs MNOV Comparison
THCH vs MNOV Comparison
Compare THCH & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- MNOV
- Stock Information
- Founded
- THCH 2018
- MNOV 2000
- Country
- THCH China
- MNOV United States
- Employees
- THCH N/A
- MNOV N/A
- Industry
- THCH Blank Checks
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- MNOV Health Care
- Exchange
- THCH Nasdaq
- MNOV Nasdaq
- Market Cap
- THCH 73.0M
- MNOV 76.5M
- IPO Year
- THCH N/A
- MNOV 2005
- Fundamental
- Price
- THCH $2.63
- MNOV $1.47
- Analyst Decision
- THCH
- MNOV Strong Buy
- Analyst Count
- THCH 0
- MNOV 1
- Target Price
- THCH N/A
- MNOV $9.00
- AVG Volume (30 Days)
- THCH 9.8K
- MNOV 9.6K
- Earning Date
- THCH 06-04-2025
- MNOV 05-16-2025
- Dividend Yield
- THCH N/A
- MNOV N/A
- EPS Growth
- THCH N/A
- MNOV N/A
- EPS
- THCH N/A
- MNOV N/A
- Revenue
- THCH $190,593,087.00
- MNOV N/A
- Revenue This Year
- THCH N/A
- MNOV N/A
- Revenue Next Year
- THCH N/A
- MNOV N/A
- P/E Ratio
- THCH N/A
- MNOV N/A
- Revenue Growth
- THCH N/A
- MNOV N/A
- 52 Week Low
- THCH $2.15
- MNOV $1.12
- 52 Week High
- THCH $6.00
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- THCH 43.75
- MNOV 48.15
- Support Level
- THCH $2.61
- MNOV $1.46
- Resistance Level
- THCH $2.84
- MNOV $1.55
- Average True Range (ATR)
- THCH 0.13
- MNOV 0.06
- MACD
- THCH 0.01
- MNOV 0.00
- Stochastic Oscillator
- THCH 48.94
- MNOV 25.00
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.